Short Interest in BIO-key International, Inc. (NASDAQ:BKYI) Drops By 36.3%

BIO-key International, Inc. (NASDAQ:BKYIGet Free Report) was the target of a large decrease in short interest in April. As of April 15th, there was short interest totalling 54,300 shares, a decrease of 36.3% from the March 31st total of 85,300 shares. Based on an average daily trading volume, of 281,000 shares, the short-interest ratio is currently 0.2 days. Approximately 2.7% of the shares of the company are sold short.

BIO-key International Stock Down 6.8 %

BKYI opened at $0.74 on Tuesday. The business has a 50 day simple moving average of $0.90 and a 200-day simple moving average of $1.09. The stock has a market capitalization of $2.31 million, a P/E ratio of -0.33 and a beta of 0.49. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.78 and a quick ratio of 0.71. BIO-key International has a 12 month low of $0.52 and a 12 month high of $3.68.

BIO-key International (NASDAQ:BKYIGet Free Report) last posted its quarterly earnings results on Thursday, March 27th. The technology company reported ($0.53) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.18). BIO-key International had a negative return on equity of 3,124.77% and a negative net margin of 72.53%. The company had revenue of $1.46 million for the quarter, compared to analyst estimates of $2.29 million.

About BIO-key International

(Get Free Report)

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

Featured Articles

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.